Bilcare Ltd · NSE:BI

Bilcare — Investor Presentation (March 2016)

19 slides from Bilcare's investor presentation, March 2016

  1. Slide 1: Corporate Overview

    Speed | Innovation | Happiness Corporate Overview

  2. Slide 2: Contents

    Contents Bilcare Overview Businesses Business Strategy Financial Overview Speed | Innovation | Happiness 2

  3. Slide 3: Bilcare Overview

    Bilcare Overview Speed | Innovation | Happiness 3

  4. Slide 4: Our Objective

    Bilcare Overview Our Objective Vision Delivering Innovation – Transforming Lives Values Speed Innovation Happiness Proactive and swift action Our constant approach at We are motivated by our is our mantra all levels is to seek better customer's success and ways of listening, thinking happiness of ou

  5. Slide 5: Business Overview

    Bilcare Overview Business Overview Market position Revenues Customers Global Footprint People Leading provider of Research Plants in 9 Team of 1800+ Over 2500 based USD 600 million locations across strong customers Innovative in revenues Europe, US and professionals globally packaging Asia globally

  6. Slide 6: Global footprint with world-class production facilities in America, Europe and Asia

    ee Global footprint with world-class production facilities in America, Europe and Asia Delaware, USA Staufen, Germany = . Bétzingen, Germany Sel te Castiglione, Italy Changi, Singapore 1D, ss Thane, India Nasik, India Pune, India 6

  7. Slide 7: Corporate Structure

    ee Corporate Structure Bilcare India > Bilcare Overview Bilcare Bilcare Singapore Mauritiu: 100% 100% Research AG 100% Bilcare Technologies Italia 92% f T 1 > \ Bilcare Bilcare Research aoe a ae 100% 100%

  8. Slide 8: Businesses

    Businesses Speed | Innovation | Happiness 8

  9. Slide 9: Business Verticals

    Businesses Business Verticals nonClonableIDTM Bilcare Solutions Global Clinical Supplies Technologies Pharma Packaging Accelerating drug Innovations development process – Anytime, Anywhere Authentication and Track- Solutions for Clinical Trial and-Trace technology for Programs; facilitating speed pe

  10. Slide 10: Bilcare Solutions

    Businesses Bilcare Solutions Pharma Packaging Pioneers in providing a wide range of pharmaceutical films & foils, to suit Innovations the sensitivity of the drug and strengthen its brand equity Packaging Films Leading suppliers of wide range of rigid Mono films for Food & Solutions FMCG industry Hig

  11. Slide 11: Global Clinical Supplies

    Businesses Global Clinical Supplies Bilcare GCS provides:  Protocol design End-to-end clinical supplies  Regulatory compliance & patient safety management services;  Batch manufacturing facilitating speed to market  Packaging design  Clinical packaging and randomization  Storage and global dis

  12. Slide 12: nonClonableID Technologies

    Businesses nonClonableIDTM Technologies Wide range of Applications nonClonableIDTM Benefits Anytime, Anywhere Authentication and Track-and- Trace technology for people and  Security & ID Cards  Better visibility throughout the products.  Document Security supply chain  Currency Security  Reliab

  13. Slide 13: nonClonableID Technologies: Authentication and Track 'n' Trace

    Businesses nonClonableIDTM Technologies Authentication and Track ‘n’ Trace Anytime, Anywhere How is it made? How does it work? Speed | Innovation | Happiness 13

  14. Slide 14: Business Strategy

    Business Strategy Speed | Innovation | Happiness 14

  15. Slide 15: Addressing Challenges

    Business Strategy Addressing Challenges Compliance Bilcare Counterfeit Packaging Solutions Communication Convenience Cost Global Regulatory hurdles Clinical R&D and Innovation pipeline deficit Supplies Lack of patient population for enrollment Brand Protection nonClonableIDTM Technologies Lack of Au

  16. Slide 16: Financial Overview

    Financial Overview Speed | Innovation | Happiness 16

  17. Slide 17: Profit & Loss Account Consolidated

    a Profit & Loss Account CONSOLIDATED >> Financial Overview USD Mn. Revenue (incl. other income) 208.33 455.20 713.34 653.50 Contribution 92.79 200.15 304.98 271.44 % of Revenue 45% 44% 43% 42% Fixed Expenses 41.99 126.47 210.37 199.34 EBITA 50.80 73.67 94.61 72.10 % of Revenue 24% 16% 13% 11% Intere

  18. Slide 18: Balance Sheet Consolidated

    ee Balance Sheet CONSOLIDATED yr >> Financial Overview USD Mn. Ss eee Equity Capital 4.44 4.60 4.60 4.33 Networth (incl. deferred tax) 189.03 244.00 301.67 277.01 Debt 117.15 238.42 267.90 391.99 TOTAL 310.62 487.02 574.17 673.33 Net Fixed Assets 173.56 282.24 320.01 430.34 Investments 0.00 0.04 0.0

  19. Slide 19: Thank you!

    Thank you! visit us at www.bilcare.com Speed | Innovation | Happiness 19

Bilcare — Investor Presentation (March 2016) on 6ix